Loading…

Endovascular Brachytherapy Using Liquid Beta-Emitting Rhenium-188 for the Treatment of Long-Segment Femoropopliteal In-Stent Stenosis

Purpose To evaluate the efficacy and safety of endovascular brachytherapy with liquid beta-emitting rhenium-188 (Re-188) in patients with long-segment in-stent stenosis in the femoropopliteal segment. Methods From July 2009 to April 2011, 90 consecutive patients (59 men; mean age 68.3±10.3 years, ra...

Full description

Saved in:
Bibliographic Details
Published in:Journal of endovascular therapy 2012-08, Vol.19 (4), p.467-475
Main Authors: Werner, Martin, Scheinert, Dierk, Henn, Marcela, Scheinert, Susanne, Bräunlich, Sven, Bausback, Yvonne, Friedenberger, Josef, Schuster, Johannes, Hertting, Klaus, Piorkowski, Michael, Rosner, Christian, Schmidt, Andrej, Ulrich, Matthias, Gutberlet, Matthias
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To evaluate the efficacy and safety of endovascular brachytherapy with liquid beta-emitting rhenium-188 (Re-188) in patients with long-segment in-stent stenosis in the femoropopliteal segment. Methods From July 2009 to April 2011, 90 consecutive patients (59 men; mean age 68.3±10.3 years, range 43–86) with symptomatic in-stent stenosis/occlusion (24.6-cm mean lesion length) of the femoropopliteal segment underwent angioplasty and subsequent endovascular brachytherapy. The liquid beta-emitting Re-188 was applied to the target lesion within an angioplasty balloon using a dose of 13 Gy at a depth of 2 mm into the vessel wall. Clinical and angiographic follow-up data were collected up to 2 years. The main study endpoints were the 6- and 12-month primary patency rates defined as
ISSN:1526-6028
1545-1550
DOI:10.1583/12-3832R.1